Dendritic Cells as Pharmacological Targets for the Generation of Regulatory Immunosuppressive Effectors. New Implications for Allo-Transplantation

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|12|16|1921-1930

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.12, Iss.16, 2005-08, pp. : 1921-1930

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Involvement of Dendritic Cells in Allograft Rejection New implications of Dendritic Cell-Endothelial Cell Interactions

By  

Mini Reviews in Medicinal Chemistry, Vol. 7, Iss. 4, 2007-01 ,pp. : 423-428

Bentham Science Publishers

Access to resources Recommend Favorite

New Pathways for Reactive Oxygen Species Generation in Inflammation and Potential Novel Pharmacological Targets

By  

Current Pharmaceutical Design, Vol. 10, Iss. 14, 2004-05 ,pp. : 1647-1652

Bentham Science Publishers

Access to resources Recommend Favorite

Approaches to the Pharmacological Modulation of Plasmacytoid Dendritic Cells

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 11, Iss. 2, 2011-06 ,pp. : 154-164

Bentham Science Publishers

Access to resources Recommend Favorite

Telomeres and Telomerase: Pharmacological Targets for New Anticancer Strategies?

By  

Current Cancer Drug Targets, Vol. 6, Iss. 2, 2006-01 ,pp. : 147-180

Bentham Science Publishers

Access to resources Recommend Favorite

Novel pharmacological targets and progression of new antitussive drugs

By McLeod Robbie L   Tulshian Deen B   Hey John A  

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 10, 2003-10 ,pp. : 1501-1512

Informa Healthcare

Access to resources Recommend Favorite